Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02778490 · ClinicalTrials.gov registry record
Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton
A clinical trial of Morbid Obesity and Calcium Metabolism Disorders, sponsored by San Francisco Veterans Affairs Medical Center.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT02778490: Completed study of Morbid Obesity and Calcium Metabolism Disorders, sponsored by San Francisco Veterans Affairs Medical Center.
NCT02778490 is a study of Morbid Obesity and Calcium Metabolism Disorders that has completed, run by San Francisco Veterans Affairs Medical Center. The registered enrollment target is 60 participants, below the 119-participant average among 24 other Morbid Obesity trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02778490, a study of Morbid Obesity and Calcium Metabolism Disorders, has completed, sponsored by San Francisco Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
In this pre-post observational study, the investigators will enroll and follow a cohort of about 50 adults undergoing sleeve gastrectomy surgery for weight loss. Pre-operatively and at 6 and 12 months post-operatively, the investigators will use state-of-the-art metabolic and imaging techniques to evaluate calcium metabolism and skeletal health. Specific outcomes include intestinal calcium absorption capacity, bone mineral density (BMD) assessed by dual-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT), and bone structure assessed by QCT and high-resolution peripheral QCT (HR-pQCT).
Primary Outcome
The investigators will determine whether there is a change in intestinal calcium absorption, assessed using the dual stable isotopes Ca-43 and Ca-44 in the setting of robust vitamin D status, following sleeve gastrectomy.
Conditions Studied
Study Locations (1)
California
- UCSF - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-06-15 |
| Est. Completion | 2021-11-28 |
What the finished NCT02778490 record still lists
NCT02778490 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 119-participant average among 24 other Morbid Obesity trials with a reported enrollment target (50% lower).
The record links to 2 conditions, with Morbid Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT02778490 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02778490 about?
NCT02778490 is a clinical study titled "Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton". In this pre-post observational study, the investigators will enroll and follow a cohort of about 50 adults undergoing sleeve gastrectomy surgery for weight loss. Pre-operatively and at 6 and 12 months post-operatively, the investigators will use state-of-the-art metabolic and imaging techniques to e...
What is the current status of trial NCT02778490?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2016-06-15. Estimated completion is 2021-11-28.
What conditions does trial NCT02778490 study?
This clinical trial studies the following conditions: Morbid Obesity, Calcium Metabolism Disorders.
Who is sponsoring clinical trial NCT02778490?
This trial is sponsored by San Francisco Veterans Affairs Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02778490 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morbid Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02778490's enrollment target sits among peer trials
60 15th of 24 higher than 9 of 24 other Morbid Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Induction of Labor in Morbidly Obese Patients
RECRUITING · Early Phase 1
-
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
RECRUITING
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
Gut Microbiota in Metabolic Surgery
RECRUITING
-
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
RECRUITING · NA
-
Metabolic Responses to Bariatric Surgery
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI